A detailed history of M&T Bank Corp transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, M&T Bank Corp holds 4,316 shares of LNTH stock, worth $338,806. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,316
Previous 5,159 16.34%
Holding current value
$338,806
Previous $319,000 15.99%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

SELL
$51.07 - $68.26 $43,052 - $57,543
-843 Reduced 16.34%
4,316 $268,000
Q4 2023

Feb 06, 2024

BUY
$55.6 - $77.89 $286,840 - $401,834
5,159 New
5,159 $319,000
Q2 2023

Aug 09, 2023

SELL
$82.41 - $99.65 $160,452 - $194,018
-1,947 Reduced 41.8%
2,711 $227,000
Q1 2023

May 11, 2023

SELL
$47.76 - $82.86 $4,059 - $7,043
-85 Reduced 1.79%
4,658 $384,000
Q4 2022

Feb 13, 2023

SELL
$48.76 - $77.67 $26,086 - $41,553
-535 Reduced 10.14%
4,743 $241,000
Q4 2022

Feb 13, 2023

SELL
$48.76 - $77.67 $32,425 - $51,650
-665 Reduced 11.19%
5,278 $268,000
Q3 2022

Nov 14, 2022

SELL
$61.42 - $86.29 $35,746 - $50,220
-582 Reduced 8.92%
5,943 $385,000
Q2 2022

Aug 05, 2022

SELL
$55.54 - $72.65 $112,301 - $146,898
-2,022 Reduced 23.66%
6,525 $399,000
Q1 2022

May 09, 2022

SELL
$24.28 - $56.64 $70,776 - $165,105
-2,915 Reduced 25.43%
8,547 $474,000
Q4 2021

Feb 07, 2022

SELL
$22.54 - $30.44 $19,068 - $25,752
-846 Reduced 6.87%
11,462 $331,000
Q3 2021

Oct 28, 2021

BUY
$24.23 - $28.59 $363 - $428
15 Added 0.12%
12,308 $318,000
Q2 2021

Aug 13, 2021

BUY
$19.51 - $27.64 $14,749 - $20,895
756 Added 6.55%
12,293 $339,000
Q1 2021

May 06, 2021

SELL
$13.77 - $21.66 $40,924 - $64,373
-2,972 Reduced 20.48%
11,537 $247,000
Q4 2020

Feb 12, 2021

BUY
$10.75 - $14.91 $155,971 - $216,329
14,509 New
14,509 $195,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $5.4B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track M&T Bank Corp Portfolio

Follow M&T Bank Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.